Foghorn Therapeutics (FHTX) Prepaid Assets (2019 - 2026)

Foghorn Therapeutics' (FHTX) quarterly Prepaid Assets came in at $3.2 million in Q1 2026, down 34.09% year-on-year from $4.8 million in Q1 2025, and up 2.98% quarter-over-quarter from $3.1 million in Q4 2025.

Foghorn Therapeutics (FHTX) Prepaid Assets (2019 - 2026) Analysis & Trends

Foghorn Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets fell 34.09% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 34.09% decrease from a year earlier, with the FY2025 full-year figure at $3.1 million, down 47.2% from the prior year.
  • Prepaid Assets improved to $3.2 million in Q1 2026 per FHTX's latest filing, from $3.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $6.2 million in Q2 2023 and bottomed at $2.6 million in Q3 2025.
  • The 5-year median for Prepaid Assets is $4.8 million (2025), against an average of $4.7 million.
  • Across the five-year window, Prepaid Assets surged 57.02% in 2022 and sank 47.2% in 2025, its largest moves.
  • Year by year, Prepaid Assets stood at $5.6 million in 2022, then increased by 9.34% to $6.1 million in 2023, then declined by 4.41% to $5.9 million in 2024, then sank by 47.2% to $3.1 million in 2025, then gained by 2.98% to $3.2 million in 2026.
  • Per Business Quant, the three latest FHTX Prepaid Assets figures stand at $3.2 million (Q1 2026), $3.1 million (Q4 2025), and $2.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Foghorn Therapeutics 352.57 Mn 263.66 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.18 Mn
Dec 31, 2025 3.09 Mn
Sep 30, 2025 2.59 Mn
Jun 30, 2025 3.93 Mn
Mar 31, 2025 4.83 Mn
Dec 31, 2024 5.85 Mn
Sep 30, 2024 3.84 Mn
Jun 30, 2024 4.44 Mn
Mar 31, 2024 4.86 Mn
Dec 31, 2023 6.12 Mn
Sep 30, 2023 5.55 Mn
Jun 30, 2023 6.18 Mn
Mar 31, 2023 4.73 Mn
Dec 31, 2022 5.60 Mn
Sep 30, 2022 4.24 Mn
Jun 30, 2022 5.34 Mn
Mar 31, 2022 5.09 Mn
Dec 31, 2021 5.27 Mn
Sep 30, 2021 3.11 Mn
Jun 30, 2021 3.40 Mn